The Levels of Regulatory T Lymphocytes and B Cells in Patients with Graves' Disease after Thyroidectomy

M. Dudina, S. Dogadin, A. Savchenko, V. D. Belenyuk, V.А. Mankovsky, A. Borisov
{"title":"The Levels of Regulatory T Lymphocytes and B Cells in Patients with Graves' Disease after Thyroidectomy","authors":"M. Dudina, S. Dogadin, A. Savchenko, V. D. Belenyuk, V.А. Mankovsky, A. Borisov","doi":"10.31550/1727-2378-2023-22-4-70-76","DOIUrl":null,"url":null,"abstract":"Aim: To study the levels of regulatory T lymphocytes (Treg) and B-cells in peripheral blood in patients with Graves' disease in dynamics after thyroidectomy. Design: Single center, observational, prospective, cohort, open, controlled study. Materials and methods. The study included 96 patients with Graves' disease, mean age 42.86 ± 10.81 years. Clinical, hormonal and immunological examinations were performed against the background of persistent drug-induced euthyroidism, before surgery, and also 1, 3, and 6 months after thyroidectomy. The levels of Treg and B-cells in the blood was examined by flow cytometry using direct immunofluorescence and monoclonal antibodies. The level of antibodies to thyroid-stimulating hormone receptors (rTSH) was assessed by enzyme immunoassay. The control group consisted of 85 healthy women of the same age. Results. In patients with Graves' disease in the dynamics of the postoperative period, there was a consistent statistically significant decrease in the titer of antibodies to rTSH: from 14.69 (8.67–19.81) to 0.81 (0.59–0.93) IU/l. The absolute amount of Treg in their blood was reduced relative to the control values already in the preoperative period and decreased even more at 6 months after thyroidectomy. The proportion of CD19+CD5+- and CD19+CD5–-cells in the examined patients before surgery was significantly higher than in the control group. The content of CD19+CD5+ cells decreased as early as 1 month after thyroidectomy and remained at the level of control values. The сontent of CD19+CD27–-cells in patients with Graves' disease in the preoperative period was higher than in the control group, decreased to the control values 1 month after thyroidectomy and remained in this range until the end of the follow-up. The content of CD19+CD27+ cells in patients before thyroidectomy was lower compare to control, in the period of 1–3 months it corresponded to the control values, but decreased again on the 6th month after surgery. Conclusion. The reduction of Treg and B-memory cells in the peripheral blood in patients with Graves' disease six months after thyroidectomy remains of immunosuppressive regulatory mechanisms with an increase in the migration activity of immune cells for a long time. Keywords: Graves' disease, thyroidectomy, regulatory T lymphocytes, memory B cells, target therapy.","PeriodicalId":11479,"journal":{"name":"Doctor.Ru","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Doctor.Ru","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31550/1727-2378-2023-22-4-70-76","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To study the levels of regulatory T lymphocytes (Treg) and B-cells in peripheral blood in patients with Graves' disease in dynamics after thyroidectomy. Design: Single center, observational, prospective, cohort, open, controlled study. Materials and methods. The study included 96 patients with Graves' disease, mean age 42.86 ± 10.81 years. Clinical, hormonal and immunological examinations were performed against the background of persistent drug-induced euthyroidism, before surgery, and also 1, 3, and 6 months after thyroidectomy. The levels of Treg and B-cells in the blood was examined by flow cytometry using direct immunofluorescence and monoclonal antibodies. The level of antibodies to thyroid-stimulating hormone receptors (rTSH) was assessed by enzyme immunoassay. The control group consisted of 85 healthy women of the same age. Results. In patients with Graves' disease in the dynamics of the postoperative period, there was a consistent statistically significant decrease in the titer of antibodies to rTSH: from 14.69 (8.67–19.81) to 0.81 (0.59–0.93) IU/l. The absolute amount of Treg in their blood was reduced relative to the control values already in the preoperative period and decreased even more at 6 months after thyroidectomy. The proportion of CD19+CD5+- and CD19+CD5–-cells in the examined patients before surgery was significantly higher than in the control group. The content of CD19+CD5+ cells decreased as early as 1 month after thyroidectomy and remained at the level of control values. The сontent of CD19+CD27–-cells in patients with Graves' disease in the preoperative period was higher than in the control group, decreased to the control values 1 month after thyroidectomy and remained in this range until the end of the follow-up. The content of CD19+CD27+ cells in patients before thyroidectomy was lower compare to control, in the period of 1–3 months it corresponded to the control values, but decreased again on the 6th month after surgery. Conclusion. The reduction of Treg and B-memory cells in the peripheral blood in patients with Graves' disease six months after thyroidectomy remains of immunosuppressive regulatory mechanisms with an increase in the migration activity of immune cells for a long time. Keywords: Graves' disease, thyroidectomy, regulatory T lymphocytes, memory B cells, target therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺切除术后Graves病患者调节性T淋巴细胞和B细胞水平的变化
目的:探讨甲状腺切除术后Graves病患者外周血调节性T淋巴细胞(Treg)和b细胞水平的动态变化。设计:单中心、观察性、前瞻性、队列、开放、对照研究。材料和方法。纳入Graves病患者96例,平均年龄42.86±10.81岁。在持续药物性甲状腺功能亢进的背景下,术前以及甲状腺切除术后1、3、6个月进行临床、激素和免疫学检查。流式细胞术采用直接免疫荧光和单克隆抗体检测血液中Treg和b细胞的水平。酶免疫法测定促甲状腺激素受体(rTSH)抗体水平。对照组由85名相同年龄的健康女性组成。结果。Graves病患者术后动态期间,rTSH抗体滴度有统计学意义的一致性下降:从14.69(8.67-19.81)降至0.81 (0.59-0.93)IU/l。与术前对照相比,患者血液中Treg的绝对含量降低,甲状腺切除术后6个月下降幅度更大。术前被检查患者的CD19+CD5+-和CD19+CD5 -细胞比例明显高于对照组。CD19+CD5+细胞含量早在甲状腺切除术后1个月就开始下降,维持在对照组水平。Graves病患者的CD19+CD27—细胞含量在术前高于对照组,在甲状腺切除术后1个月降至对照组,并保持在该范围内直至随访结束。甲状腺切除术前患者CD19+CD27+细胞含量较对照组低,1-3个月与对照组相当,但术后6个月再次下降。结论。Graves病患者甲状腺切除术后6个月外周血Treg和b记忆细胞减少,长期保持免疫抑制调节机制,免疫细胞迁移活性增加。关键词:Graves病,甲状腺切除术,调节性T淋巴细胞,记忆B细胞,靶向治疗
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changes of the Electrical Axis of the Heart and Dyslipidemia as Possible Markers of Cardiovascular Damage in Patients after COVID-19 Successful Use of Etanercept in a Child with Еnthesitis-Аssociated Аrthritis Social and Metabolic Risk Factors for Arterial Hypertension in Adolescents Respiratory Rehabilitation of COVID-19 Patients: Current State of the Problem Optimization of the Functional State of the Cardiovascular System of Children Who Have Experienced the Stress of Military Operations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1